Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

J Can Assoc Gastroenterol. 2019 Aug;2(3):e1-e34. doi: 10.1093/jcag/gwz019. Epub 2018 Jul 10.

2.

Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure.

Bressler B, Williamson M, Sattin B, Camacho F, Steinhart AH.

J Can Assoc Gastroenterol. 2018 Sep;1(3):129-134. doi: 10.1093/jcag/gwy019. Epub 2018 May 10.

3.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1680-1713. doi: 10.1016/j.cgh.2019.02.043. Epub 2019 Mar 7.

PMID:
30853616
4.

The Unsolved Link of Genetic Markers and Crohn's Disease Progression: A North American Cohort Experience.

O'Donnell S, Borowski K, Espin-Garcia O, Milgrom R, Kabakchiev B, Stempak J, Panikkath D, Eksteen B, Xu W, Steinhart AH, Kaplan GG, McGovern DPB, Silverberg MS.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1541-1549. doi: 10.1093/ibd/izz016.

PMID:
30801121
5.

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Rheumatol. 2019 Jul;46(7):751-754. doi: 10.3899/jrheum.180784. Epub 2019 Feb 1.

6.

Budesonide for the Induction and Maintenance of Remission in Crohn's Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration.

Kuenzig ME, Rezaie A, Kaplan GG, Otley AR, Steinhart AH, Griffiths AM, Benchimol EI, Seow CH.

J Can Assoc Gastroenterol. 2018 Dec;1(4):159-173. doi: 10.1093/jcag/gwy018. Epub 2018 May 24.

7.

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Cutan Med Surg. 2019 Jan/Feb;23(1):50-74. doi: 10.1177/1203475418811335. Epub 2018 Nov 21.

8.

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Steinhart AH, Panaccione R, Targownik L, Bressler B, Khanna R, Marshall JK, Afif W, Bernstein CN, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C.

Inflamm Bowel Dis. 2019 Jan 1;25(1):1-13. doi: 10.1093/ibd/izy247.

PMID:
30099529
9.

Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.

Weizman AV, Sharma R, Afzal NM, Xu W, Walsh S, Stempak JM, Nguyen GC, Croitoru K, Steinhart AH, Silverberg MS.

Dig Dis Sci. 2018 Sep;63(9):2430-2438. doi: 10.1007/s10620-018-5096-2. Epub 2018 May 8.

PMID:
29736839
10.

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease.

Greener T, Kabakchiev B, Steinhart AH, Silverberg MS.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1808-1814. doi: 10.1093/ibd/izy066.

PMID:
29697810
11.

Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?

Steinhart AH.

Inflamm Bowel Dis. 2018 Mar 19;24(4):669-670. doi: 10.1093/ibd/izx099. No abstract available.

PMID:
29547993
12.

The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn's Disease.

Greener T, Boland K, Steinhart AH, Silverberg MS.

J Crohns Colitis. 2018 Mar 28;12(4):458-464. doi: 10.1093/ecco-jcc/jjx176.

PMID:
29293965
13.

Reply.

Janmohamed N, Steinhart AH.

Inflamm Bowel Dis. 2017 Nov;23(11):E54-E55. doi: 10.1097/MIB.0000000000001284. No abstract available.

PMID:
29040140
14.

Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders-Ulcerative Colitis (ADORE-UC) Study.

Gallinger ZR, Rumman A, Pivovarov K, Fortinsky KJ, Steinhart AH, Weizman AV.

Inflamm Bowel Dis. 2017 Oct;23(10):1790-1795. doi: 10.1097/MIB.0000000000001244.

PMID:
28906293
15.

Characterizing the Posttransfer Period Among Patients with Pediatric Onset IBD: The Impact of Academic Versus Community Adult Care on Emergent Health Resource Utilization.

Bollegala N, Benchimol EI, Griffiths AM, Kovacs A, Steinhart AH, Zhao X, Nguyen GC.

Inflamm Bowel Dis. 2017 Sep;23(9):1483-1491. doi: 10.1097/MIB.0000000000001200.

PMID:
28816756
16.

Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists.

Janmohamed N, Steinhart AH.

Inflamm Bowel Dis. 2017 Jul;23(7):1168-1173. doi: 10.1097/MIB.0000000000001107.

PMID:
28613229
17.

Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.

Kelly OB, Donnell SO, Stempak JM, Steinhart AH, Silverberg MS.

Inflamm Bowel Dis. 2017 Jul;23(7):1202-1209. doi: 10.1097/MIB.0000000000001126.

PMID:
28498155
18.

Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease.

Zittan E, Kabakchiev B, Kelly OB, Milgrom R, Nguyen GC, Croitoru K, Steinhart AH, Silverberg MS.

J Crohns Colitis. 2017 May 1;11(5):543-548. doi: 10.1093/ecco-jcc/jjw200.

PMID:
28453763
19.

Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.

Narula N, Borges L, Steinhart AH, Colombel JF.

Inflamm Bowel Dis. 2017 Jun;23(6):868-874. doi: 10.1097/MIB.0000000000001084.

PMID:
28368911
20.

Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease.

Rumman A, Candia R, Sam JJ, Croitoru K, Silverberg MS, Steinhart AH, Nguyen GC.

Can J Gastroenterol Hepatol. 2017;2017:7365937. doi: 10.1155/2017/7365937. Epub 2017 Jan 23.

21.

Preventive care for a 35-year-old woman with inflammatory bowel disease.

Narula N, Steinhart AH.

CMAJ. 2017 Feb 13;189(6):E243-E244. doi: 10.1503/cmaj.160640. No abstract available.

22.

Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis.

Zittan E, Milgrom R, Ma GW, Wong-Chong N, OʼConnor B, McLeod RS, MacRae HM, Greenberg GR, Nguyen GC, Croitoru K, Steinhart AH, Cohen Z, Silverberg MS.

Inflamm Bowel Dis. 2016 Oct;22(10):2442-7. doi: 10.1097/MIB.0000000000000919.

PMID:
27607335
23.

Quality Improvement Primer Series: The Plan-Do-Study-Act Cycle and Data Display.

Bollegala N, Patel K, Mosko JD, Bernstein M, Brahmania M, Liu L, Steinhart AH, Silver SS, Bell CM, Nguyen GC, Weizman AV.

Clin Gastroenterol Hepatol. 2016 Sep;14(9):1230-3. doi: 10.1016/j.cgh.2016.04.042. Epub 2016 May 20. No abstract available.

PMID:
27211505
24.

Quality Improvement Primer Series: Launching a Quality Improvement Initiative.

Weizman AV, Mosko J, Bollegala N, Bernstein M, Brahmania M, Liu L, Steinhart AH, Silver SS, Bell CM, Nguyen GC.

Clin Gastroenterol Hepatol. 2016 Aug;14(8):1067-71. doi: 10.1016/j.cgh.2016.04.041. Epub 2016 May 20. No abstract available.

PMID:
27211504
25.

Quality Improvement Primer Series: How to Sustain a Quality Improvement Effort.

Bernstein M, Hou JK, Weizman AV, Mosko J, Bollegala N, Brahmania M, Liu L, Steinhart AH, Silver SS, Nguyen GC, Bell CM.

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1371-5. doi: 10.1016/j.cgh.2016.05.019. Epub 2016 May 20. No abstract available.

PMID:
27211500
26.

Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis.

Parian A, Limketkai B, Koh J, Brant SR, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro MD, Rioux JD, Schumm P, Taylor KD, Silverberg MS, Steinhart AH, Hernaez R, Lazarev M.

Gut. 2017 Aug;66(8):1390-1397. doi: 10.1136/gutjnl-2016-311550. Epub 2016 Apr 13. Review.

27.

Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study.

Nguyen GC, Croitoru K, Silverberg MS, Steinhart AH, Weizman AV.

Inflamm Bowel Dis. 2016 Jun;22(6):1412-7. doi: 10.1097/MIB.0000000000000773.

PMID:
27120570
28.

Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.

Zittan E, Kelly OB, Kirsch R, Milgrom R, Burns J, Nguyen GC, Croitoru K, Van Assche G, Silverberg MS, Steinhart AH.

Inflamm Bowel Dis. 2016 Mar;22(3):623-30. doi: 10.1097/MIB.0000000000000652.

PMID:
26829408
29.

Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease.

Zittan E, Kabakchiev B, Milgrom R, Nguyen GC, Croitoru K, Steinhart AH, Silverberg MS.

J Crohns Colitis. 2016 May;10(5):510-5. doi: 10.1093/ecco-jcc/jjw014. Epub 2016 Jan 18.

30.

Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis.

Kelly OB, Rosenberg M, Tyler AD, Stempak JM, Steinhart AH, Cohen Z, Greenberg GR, Silverberg MS.

J Crohns Colitis. 2016 Apr;10(4):410-7. doi: 10.1093/ecco-jcc/jjv225. Epub 2015 Dec 30.

31.

Oral budesonide for induction of remission in ulcerative colitis.

Sherlock ME, MacDonald JK, Griffiths AM, Steinhart AH, Seow CH.

Cochrane Database Syst Rev. 2015 Oct 26;(10):CD007698. doi: 10.1002/14651858.CD007698.pub3. Review.

PMID:
26497719
32.

Type I interferons for induction of remission in ulcerative colitis.

Wang Y, MacDonald JK, Benchimol EI, Griffiths AM, Steinhart AH, Panaccione R, Seow CH.

Cochrane Database Syst Rev. 2015 Sep 14;(9):CD006790. doi: 10.1002/14651858.CD006790.pub3. Review.

PMID:
26368001
33.

Predictors of Outcome in Ulcerative Colitis.

Waterman M, Knight J, Dinani A, Xu W, Stempak JM, Croitoru K, Nguyen GC, Cohen Z, McLeod RS, Greenberg GR, Steinhart AH, Silverberg MS.

Inflamm Bowel Dis. 2015 Sep;21(9):2097-105. doi: 10.1097/MIB.0000000000000466.

PMID:
26177304
34.

Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn's disease.

O'Donnell S, Stempak JM, Steinhart AH, Silverberg MS.

J Crohns Colitis. 2015 Oct;9(10):830-6. doi: 10.1093/ecco-jcc/jjv115. Epub 2015 Jun 26.

PMID:
26116556
35.

Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.

Murthy SK, Greenberg GR, Croitoru K, Nguyen GC, Silverberg MS, Steinhart AH.

Inflamm Bowel Dis. 2015 Sep;21(9):2090-6. doi: 10.1097/MIB.0000000000000474.

PMID:
26099066
36.

Budesonide for induction of remission in Crohn's disease.

Rezaie A, Kuenzig ME, Benchimol EI, Griffiths AM, Otley AR, Steinhart AH, Kaplan GG, Seow CH.

Cochrane Database Syst Rev. 2015 Jun 3;(6):CD000296. doi: 10.1002/14651858.CD000296.pub4. Review.

PMID:
26039678
37.

Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: The patient perspective.

Steinhart AH, Fernandes A.

Can J Gastroenterol Hepatol. 2015 Aug-Sep;29(6):294-6. Epub 2015 May 22.

38.

Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.

Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, Panaccione R, Steinhart AH, Tse F, Feagan B; Toronto Ulcerative Colitis Consensus Group.

Gastroenterology. 2015 May;148(5):1035-1058.e3. doi: 10.1053/j.gastro.2015.03.001. Epub 2015 Mar 4. Review.

PMID:
25747596
39.

The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.

Fedorak RN, Feagan BG, Hotte N, Leddin D, Dieleman LA, Petrunia DM, Enns R, Bitton A, Chiba N, Paré P, Rostom A, Marshall J, Depew W, Bernstein CN, Panaccione R, Aumais G, Steinhart AH, Cockeram A, Bailey RJ, Gionchetti P, Wong C, Madsen K.

Clin Gastroenterol Hepatol. 2015 May;13(5):928-35.e2. doi: 10.1016/j.cgh.2014.10.031. Epub 2014 Nov 6.

PMID:
25460016
40.

Budesonide for maintenance of remission in Crohn's disease.

Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, Kaplan GG, Benchimol EI.

Cochrane Database Syst Rev. 2014 Aug 21;(8):CD002913. doi: 10.1002/14651858.CD002913.pub3. Review.

PMID:
25141071
41.

The impact of surgeon volume on postoperative outcomes after surgery for Crohn's disease.

Nguyen GC, Steinhart AH.

Inflamm Bowel Dis. 2014 Feb;20(2):301-6. doi: 10.1097/01.MIB.0000438247.06595.b9.

PMID:
24374877
42.

Ileal pouch symptoms do not correlate with inflammation of the pouch.

Ben-Bassat O, Tyler AD, Xu W, Kirsch R, Schaeffer DF, Walsh J, Steinhart AH, Greenberg GR, Cohen Z, Silverberg MS, McLeod RS.

Clin Gastroenterol Hepatol. 2014 May;12(5):831-837.e2. doi: 10.1016/j.cgh.2013.09.027. Epub 2013 Sep 27.

PMID:
24075890
43.

Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease.

Khanna R, Sattin BD, Afif W, Benchimol EI, Bernard EJ, Bitton A, Bressler B, Fedorak RN, Ghosh S, Greenberg GR, Marshall JK, Panaccione R, Seidman EG, Silverberg MS, Steinhart AH, Sy R, Van Assche G, Walters TD, Sandborn WJ, Feagan BG.

Aliment Pharmacol Ther. 2013 Sep;38(5):447-59. doi: 10.1111/apt.12407. Epub 2013 Jul 14. Review.

44.

Pouchitis: a practical guide.

Steinhart AH, Ben-Bassat O.

Frontline Gastroenterol. 2013 Jul;4(3):198-204. doi: 10.1136/flgastro-2012-100171. Epub 2013 Nov 12. Review.

45.

Serum antibodies associated with complex inflammatory bowel disease.

Elkadri AA, Stempak JM, Walters TD, Lal S, Griffiths AM, Steinhart AH, Silverberg MS.

Inflamm Bowel Dis. 2013 Jun;19(7):1499-505. doi: 10.1097/MIB.0b013e318281f2a1.

PMID:
23702714
46.

The utility of screening for asymptomatic lower extremity deep venous thrombosis during inflammatory bowel disease flares: a pilot study.

Nguyen GC, Wu H, Gulamhusein A, Rosenberg M, Thanabalan R, Yeo EL, Bernstein CN, Steinhart AH, Margolis M.

Inflamm Bowel Dis. 2013 Apr;19(5):1053-8. doi: 10.1097/MIB.0b013e3182802a65.

PMID:
23429463
47.

Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium.

Lazarev M, Huang C, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro M, Rioux JD, Schumm PP, Taylor KD, Silverberg MS, Steinhart AH, Hutfless S, Brant SR.

Am J Gastroenterol. 2013 Jan;108(1):106-12. doi: 10.1038/ajg.2012.389. Epub 2012 Dec 11.

48.

Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004118. doi: 10.1002/14651858.CD004118.pub2. Review.

PMID:
23152224
49.

Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis.

Murthy SK, Steinhart AH, Tinmouth J, Austin PC, Daneman N, Nguyen GC.

Aliment Pharmacol Ther. 2012 Dec;36(11-12):1032-9. doi: 10.1111/apt.12073. Epub 2012 Oct 14.

50.

Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.

Stolla M, Pelisek J, von Brühl ML, Schäfer A, Barocke V, Heider P, Lorenz M, Tirniceriu A, Steinhart A, Bauersachs J, Bray PF, Massberg S, Schulz C.

PLoS One. 2012;7(8):e43572. doi: 10.1371/journal.pone.0043572. Epub 2012 Aug 20.

Supplemental Content

Loading ...
Support Center